. DUNNING J.
Potential adverse effects of negative publicity surrounding antivirals for
influenza.
BMJ. 2014;348:g3015.
PubMed: www.amedeo.com/p2.php?id=24788692&s=flu&pm=23198075145d987<http://www.amedeo.com/p2.php?id=24788692&s=flu&pm=23198075145d987>
Posted by Rob LW
hVIVO is the new name of Retroscreen Virology! (from 15 April 2015). hVIVO is a rapidly growing UK life sciences company pioneering a technology platform which uses human challenge models of disease involving healthy volunteers to study new drugs and investigate disease in a safe, controlled, clinical environment. Our belief is that the best way to understand human disease is by studying it in humans, not laboratory models.
No comments:
Post a Comment